"Vasodilator Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs used to cause dilation of the blood vessels.
| Descriptor ID |
D014665
|
| MeSH Number(s) |
D27.505.954.411.918
|
| Concept/Terms |
Vasodilator Agents- Vasodilator Agents
- Agents, Vasodilator
- Vasodilators
- Vasorelaxants
- Vasodilator Drugs
- Drugs, Vasodilator
|
Below are MeSH descriptors whose meaning is more general than "Vasodilator Agents".
Below are MeSH descriptors whose meaning is more specific than "Vasodilator Agents".
This graph shows the total number of publications written about "Vasodilator Agents" by people in this website by year, and whether "Vasodilator Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 2 | 3 |
| 1997 | 3 | 1 | 4 |
| 1998 | 3 | 2 | 5 |
| 1999 | 2 | 3 | 5 |
| 2000 | 2 | 3 | 5 |
| 2001 | 1 | 3 | 4 |
| 2002 | 1 | 2 | 3 |
| 2003 | 1 | 0 | 1 |
| 2004 | 1 | 4 | 5 |
| 2005 | 1 | 0 | 1 |
| 2006 | 2 | 4 | 6 |
| 2007 | 0 | 3 | 3 |
| 2008 | 2 | 5 | 7 |
| 2009 | 1 | 1 | 2 |
| 2010 | 1 | 1 | 2 |
| 2011 | 1 | 0 | 1 |
| 2012 | 0 | 2 | 2 |
| 2013 | 3 | 1 | 4 |
| 2015 | 2 | 0 | 2 |
| 2016 | 0 | 2 | 2 |
| 2017 | 1 | 4 | 5 |
| 2018 | 2 | 3 | 5 |
| 2019 | 1 | 0 | 1 |
| 2023 | 0 | 1 | 1 |
| 2025 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Vasodilator Agents" by people in Profiles.
-
Dillon GA, Harvey RE, Limberg JK, Nicholson WT, Joyner MJ, Baker SE, Miller VM, Ranadive SM. Acute exogenous oestradiol augments endothelial and smooth muscle vasodilatory responsiveness in premenopausal but not postmenopausal females. J Physiol. 2025 04; 603(8):2301-2311.
-
Goel H, Carey M, Elshaikh A, Krinock M, Goyal D, Nadar SK. Cardioprotective and Antianginal Efficacy of Nicorandil: A Comprehensive Review. J Cardiovasc Pharmacol. 2023 08 01; 82(2):69-85.
-
Chang AM, Pang PS, Butler J, Storrow AB, Levy PD, Lindenfeld J, Collins SP. Early Treatment in Emergency Department Patients with Acute Heart Failure: Does Time Matter? Curr Heart Fail Rep. 2019 02; 16(1):12-20.
-
Deljou A, Kohlenberg JD, Weingarten TN, Bancos I, Young WF, Schroeder DR, Martin DP, Sprung J. Hemodynamic instability during percutaneous ablation of extra-adrenal metastases of pheochromocytoma and paragangliomas: a case series. BMC Anesthesiol. 2018 11 06; 18(1):158.
-
Cohen JL, Nees SN, Valencia GA, Rosenzweig EB, Krishnan US. Sildenafil Use in Children with Pulmonary Hypertension. J Pediatr. 2019 02; 205:29-34.e1.
-
Baker SE, Limberg JK, Dillon GA, Curry TB, Joyner MJ, Nicholson WT. Aging Alters the Relative Contributions of the Sympathetic and Parasympathetic Nervous System to Blood Pressure Control in Women. Hypertension. 2018 11; 72(5):1236-1242.
-
Morgan RW, Sutton RM, Karlsson M, Lautz AJ, Mavroudis CD, Landis WP, Lin Y, Jeong S, Craig N, Nadkarni VM, Kilbaugh TJ, Berg RA. Pulmonary Vasodilator Therapy in Shock-associated Cardiac Arrest. Am J Respir Crit Care Med. 2018 04 01; 197(7):905-912.
-
Limberg JK, Ott EP, Holbein WW, Baker SE, Curry TB, Nicholson WT, Joyner MJ, Shoemaker JK. Pharmacological assessment of the contribution of the arterial baroreflex to sympathetic discharge patterns in healthy humans. J Neurophysiol. 2018 06 01; 119(6):2166-2175.
-
Kirkman DL, Muth BJ, Ramick MG, Townsend RR, Edwards DG. Role of mitochondria-derived reactive oxygen species in microvascular dysfunction in chronic kidney disease. Am J Physiol Renal Physiol. 2018 03 01; 314(3):F423-F429.
-
Vishnevsky A, Julien HM, Fischman DL, Walinsky P, David Ogilby J, Ruggiero NJ, Jasti B, Savage MP. Unrecognized coronary vasospasm in patients referred for percutaneous coronary intervention: Intracoronary nitroglycerin, the forgotten stepchild of cardiovascular guidelines. Catheter Cardiovasc Interv. 2017 Dec 01; 90(7):1086-1090.